Straits Times Index
3,331.70 +5.42 (+0.16%) S&P 500
5,469.57 +0.27 (+0.00%) Dow
39,172.98 +60.82 (+0.16%) Nasdaq
17,759.87 +42.21 (+0.24%) Bitcoin USD
60,917.39 -1,251.28 (-2.01%) CMC Crypto 200
1,267.00 -16.79 (-1.31%)
CI Jan 2025 130.000 put
| Previous close | 1.1000 |
| Open | 0.9000 |
| Bid | 0.3500 |
| Ask | 1.4000 |
| Strike | 130.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.9000 - 1.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksWhy Cigna (CI) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Associated Press Finance
Arkansas sues 2 pharmacy benefit managers, accusing them of fueling opioid epidemic in state
Arkansas on Monday sued two pharmacy benefit managers that oversee coverage for insurers, employers and other large clients, accusing them of fueling the opioid crisis in the state. Attorney General Tim Griffin filed the lawsuit against Express Scripts Inc. and Optum Inc., and their subsidiaries, in state court. Pharmacy benefit managers run prescription drug coverage for big clients that include health insurers and employers that provide coverage.
PR NewswireExpress Scripts by Evernorth Members Paid Less for Prescriptions in 2023 Despite Drug Price Increases
Express Scripts, the pharmacy benefits services business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today released research spotlighting that members with employer-provided coverage paid less at the pharmacy counter for prescription drugs in 2023 compared to the previous year. On average, members with employer-sponsored drug coverage paid $15.10 out-of-pocket for a 30-day prescription in 2023, a decrease of about 1% compared to 2022. While drug manufacturers raised prices for 60%
